Top

BMC Pediatrics

Published in:

Open Access 01-12-2024 | Neonatal Screening | Research

Up-to-date quality survey and evaluation of neonatal screening programs in China

Authors: Jinming Zhang, Lizi Jin, Penghui Feng, Yu Fei, Wen Li, Ting Jiang, Zehao Zhang, Falin He

Published in: BMC Pediatrics | Issue 1/2024

Abstract

Aims

To thoroughly evaluate the quality of the entire process of neonatal screening (NBS) in China.

Methods

We collected survey questionnaires from 54.4% (135/248) of NBS institutions in China and conducted on-site visits to 20 of these facilities to validate the data. The quality performance of the institutions was evaluated, and differences across various factors were analysed.

Results

Merely 62.5% of the provinces had acceptable performance in neonatal screening. Institutions with limited staff were more prone to organizational management shortcomings. Institutions in provinces with a per capita GDP below 10,000 USD exhibited lower quality control levels than those with a per capita GDP between 10,000 and 15,000 USD. Obstetrics departments have a lower awareness of quality control compared to other blood collection facilities.

Conclusions

A nationwide, comprehensive quality control system for continuous enhancements in quality management, screening, diagnosis, and treatment is imperative to ensure prompt diagnosis and intervention.

Available only for authorised users

McCabe ERB. Newborn screening system: Safety, technology, advocacy. Mol Genet Metab Sep-Oct. 2021;134(1–2):3–7. https://doi.org/10.1016/j.ymgme.2021.07.003.CrossRef

Ferreira CR, Rahman S, Keller M, Zschocke J. An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis Jan. 2021;44(1):164–77. https://doi.org/10.1002/jimd.12348.CrossRef

Qiao J, Wang Y, Li X, et al. A Lancet Commission on 70 years of women’s reproductive, maternal, newborn, child, and adolescent health in China. Lancet Jun. 2021;26(10293):2497–536. https://doi.org/10.1016/s0140-6736(20)32708-2.CrossRef

Loeber JG, Burgard P, Cornel MC, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result. J Inherit Metab Dis Jul. 2012;35(4):603–11. https://doi.org/10.1007/s10545-012-9483-0.CrossRef

Burgard P, Rupp K, Lindner M, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis Jul. 2012;35(4):613–25. https://doi.org/10.1007/s10545-012-9484-z.CrossRef

Zimmer KP. Newborn screening: still room for improvement. Dtsch Arztebl Int Feb. 2021;19(7):99–100. https://doi.org/10.3238/arztebl.m2021.0008.CrossRef

Kritzer A. Quality improvement: the tools we need to improve care for patients with inborn errors of metabolism. Mol Genet Metab Jan. 2020;129(1):1–2. https://doi.org/10.1016/j.ymgme.2019.12.009.CrossRef

McCabe ER. Newborn screening: a complex system that requires a culture of safety. Mol Genet Metab Sep-Oct. 2014;113(1–2):6–7. https://doi.org/10.1016/j.ymgme.2014.03.001.CrossRef

Sontag MK, Miller JI, McKasson S, et al. Newborn screening timeliness quality improvement initiative: impact of national recommendations and data repository. PLoS ONE. 2020;15(4):e0231050. https://doi.org/10.1371/journal.pone.0231050.CrossRefPubMedPubMedCentral

10.

Loeber JG, Platis D, Zetterström RH, et al. Neonatal screening in Europe Revisited: an ISNS perspective on the current state and developments since 2010. Int J Neonatal Screen Mar. 2021;5(1). https://doi.org/10.3390/ijns7010015.

11.

Lüders A, Blankenstein O, Brockow I, et al. Neonatal screening for congenital metabolic and endocrine disorders–results from Germany for the years 2006–2018. Dtsch Arztebl Int Feb. 2021;19(7):101–8. https://doi.org/10.3238/arztebl.m2021.0009.CrossRef

12.

German Society for Neonatal Screening (DGNS). National Screening Report Germany 2018. 2021. https://www.screening-dgns.de/reports.php.

13.

Padilla CD, Therrell BL, Panol KAR, et al. Philippine performance evaluation and Assessment Scheme (PPEAS): experiences in Newborn Screening System Quality Improvement. Int J Neonatal Screen Dec. 2020;11(4). https://doi.org/10.3390/ijns6040095.

14.

Zhong K, Wang W, He F, Wang Z. Neonatal screening external quality assessment in China, 2014. J Med Screen Dec. 2015;22(4):175–81. https://doi.org/10.1177/0969141315592924.CrossRef

15.

Yu CW, He XY, Wan KX, et al. Improving quality management of newborn screening in southwest China. J Int Med Res Apr. 2021;49(4):3000605211002999. https://doi.org/10.1177/03000605211002999.CrossRef

16.

Jin L, He F, Zhang C. Quality management of the newborn screening network: the Chinese experience. Chin Med J (Engl) Mar. 2023;15. https://doi.org/10.1097/cm9.0000000000002386.

17.

NH C. Notice of the National Health Commission on the Issuance. of the Implementation Plan for the 2021–2030 China Women and Children Development Outline 2022. http://www.gov.cn/zhengce/zhengceku/2022-04/09/content_5684258.htm.

18.

Harris M. Simple screening comparisons between countries mask complex differences. https://nationalscreening.blog.gov.uk/2023/02/15/simple-screening-comparisons-between-countries-mask-complex-differences/#:~:text=Current%20uptake%20of%20newborn%20screening%20in%20the%20UK,this%20very%20high%20public%20trust%20to%20be%20reduced.

19.

Jew K, Kan K, Koch R, Cunningham GC. Validity of screening early collected newborn specimens for phenylketonuria using a fluorometric method. Screening. 1994;3(1):1–9. https://doi.org/10.1016/0925-6164(94)90030-2.CrossRef

20.

Nagasaki K, Minamitani K, Nakamura A, et al. Guidelines for newborn screening of congenital hypothyroidism (2021 revision). Clin Pediatr Endocrinol. 2023;32(1):26–51. https://doi.org/10.1297/cpe.2022-0063.CrossRefPubMed

21.

Newborn screening. Toward a uniform screening panel and system–executive summary. Pediatr May. 2006;117(5 Pt 2):296–307. https://doi.org/10.1542/peds.2005-2633I.CrossRef

22.

Kanungo S, Patel DR, Neelakantan M, Ryali B. Newborn screening and changing face of inborn errors of metabolism in the United States. Ann Transl Med Dec. 2018;6(24):468. https://doi.org/10.21037/atm.2018.11.68.CrossRef

23.

Odenwald B, Brockow I, Hanauer M, Lüders A, Nennstiel U. Is our newborn screening Working Well? A Literature Review of Quality requirements for newborn blood spot screening (NBS) infrastructure and procedures. Int J Neonatal Screen Jun. 2023;22(3). https://doi.org/10.3390/ijns9030035.

24.

England N. https://www.gov.uk/government/publications/health-professional-handbook-newborn-blood-spot-screening/2-screening-pathway.

25.

Cornel MCRT, Weinreich SS, Burgard P, Hoffmann GF, Lindner M, Gerard Loeber J, Rupp K, Taruscio D, Vittozzi L. Newborn screening in Europe: Expert Opinion Document 2011. https://isns-neoscreening.org/wp-content/uploads/2018/11/Expert-opinion-document-on-NBS-FINAL.pdf.

26.

Gramer G, Brockow I, Labitzke C, et al. Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis-implications for process quality and patient care. Eur J Pediatr Apr. 2021;180(4):1145–55. https://doi.org/10.1007/s00431-020-03849-4.CrossRef

27.

Cornel MC, Rigter T, Weinreich SS, et al. A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document. Eur J Hum Genet Jan. 2014;22(1):12–7. https://doi.org/10.1038/ejhg.2013.90.CrossRef

28.

Sikonja J, Groselj U, Scarpa M, et al. Towards Achieving Equity and Innovation in Newborn Screening across Europe. Int J Neonatal Screen May. 2022;6(2). https://doi.org/10.3390/ijns8020031.

29.

Scarpa M, Bonham JR, Dionisi-Vici C, et al. Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe. Lancet Reg Health Eur Feb. 2022;13:100311. https://doi.org/10.1016/j.lanepe.2022.100311.CrossRef

Title: Up-to-date quality survey and evaluation of neonatal screening programs in China
Authors: Jinming Zhang
Lizi Jin
Penghui Feng
Yu Fei
Wen Li
Ting Jiang
Zehao Zhang
Falin He
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Neonatal Screening
Published in: BMC Pediatrics / Issue 1/2024
Electronic ISSN: 1471-2431
DOI: https://doi.org/10.1186/s12887-024-04528-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Up-to-date quality survey and evaluation of neonatal screening programs in China

Abstract

Aims

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aims

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Assessment of nutritional status, physical fitness and physical activity of school going adolescents (12–15 years) in Delhi

Biochemical profiles and organ dysfunction in neonates with hypoxic-ischemic encephalopathy post-hoc analysis of the THIN trial

Multiple behavioral risk factors for non-communicable diseases among the adolescent population in Brazil: the analysis derived from the Brazilian national survey of school health 2019

Risk factors of multidrug-resistant organisms neonatal sepsis in Surabaya tertiary referral hospital: a single-center study

Relationship between sleep disturbance and developmental status in preschool-aged children with developmental disorder

Delayed onset of neonatal compartment syndrome associated with compound fetal presentation